Curis Lifesciences

Curis Lifesciences

141.00
+13.00
(10.16%)
ann
Q1 Quarterly Results are out. Check out the updated financials16 hours ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
Market Cap
114.00 Cr
EPS
10.29
PE Ratio
21.27
Dividend Yield
0.00 %
Industry
-
52 Week High
0.00
52 Week Low
0.00
PB Ratio
3.04
Debt to Equity
1.48
Sector
-
Forecast For
Actual
Growth Rate
Revenue Growth
38.16 %
Net Income Growth
12.96 %
Cash Flow Change
-728.57 %
ROE
-60.11 %
ROCE
-29.27 %
EBITDA Margin (Avg.)
-16.98 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Revenue
9
Expenses
6
EBITDA
3
Operating Profit %
30 %
Depreciation
0
Interest
0
Profit Before Tax
2
Tax
1
Net Profit
1
EPS in ₹
24.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
27
30
34
43
Fixed Assets
12
12
12
11
Current Assets
15
17
22
31
Capital Work in Progress
0
0
0
0
Investments
0
0
0
0
Other Assets
15
18
22
32
Total Liabilities
27
30
34
43
Current Liabilities
16
19
19
18
Non Current Liabilities
13
10
10
9
Total Equity
-1
0
6
16
Reserve & Surplus
-1
-0
5
10
Share Capital
1
1
1
6

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
0
0
-0
Investing Activities
-0
-1
-0
0
Operating Activities
5
3
0
-2
Financing Activities
-5
-3
0
2

Share Holding

% Holding
Dec 2024
Promoter
92.68 %
FIIs
0.00 %
DIIs
0.00 %
Government
0.00 %
Public / Retail
4.37 %
Others
2.95 %
No of Share Holders
27

Technical Indicators